封面
市场调查报告书
商品编码
1705795

血小板浓缩系统市场(按技术、应用、最终用户和地区)

Platelet Concentration Systems Market, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球血小板浓缩器市场规模估计为 5.458 亿美元,预计到 2032 年将达到 10.911 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 10.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 5.458亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 10.40% 2032年价值预测 10.911亿美元
数字。 2025年血小板浓缩系统各地区市场占有率(%)
血小板浓缩系统市场-IMG1

血小板浓缩系统是用于浓缩从捐赠血液中收集的血小板的重要医疗设备。从这些系统中获得的富血小板血浆(PRP)比正常血液含有更高的血小板密度。 PRP 被定义为血小板浓度高于正常血浆的血浆,是透过自体血液的离心或重力过滤产生的。 PRP 广泛应用于各种再生医学应用,包括治疗肌肉、骨骼和关节损伤的整形外科手术。该系统采用先进技术,透过离心将血小板与其他血液成分精确分离,然后小心地将它们压缩成浓缩製剂。它提供安全且临床有效量的自体 PRP 来增强身体的自然癒合过程。随着全球人口老化和运动伤害的增加,对微创血小板富集技术的需求日益增加。

市场动态:

全球血小板浓缩系统市场受到慢性疾病、运动伤害和创伤性损伤发病率上升的推动,这些疾病可以从 PRP 疗法中受益匪浅。重组手术中组织工程方法的采用日益增多以及伤口护理中对血液衍生产品的依赖日益增加,正在推动市场成长。然而,这些设备成本高昂,而且一些地区缺乏基于 PRP 的治疗报销政策,阻碍了它们的广泛应用。此外,每个系统都需要监管部门的批准,这对市场进入者来说是一个挑战。尚未开发的商机存在于人口老化的新兴经济体以及利用血小板浓缩物进行新的医疗应用。预计在预测期内,持续的研究和开发将提高浓缩精度、实现流程自动化并扩大应用范围,从而带来良好的前景。

本研究的主要特点

  • 本报告对全球血小板浓缩系统市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2024-2030 年)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 全球血小板浓缩系统市场的主要企业根据公司亮点、产品系列、关键亮点、性能和策略等参数进行分析。
  • 本研究介绍的主要企业包括 Anthrax Inc.、Stryker Corporation、Johnson & Johnson's、Zimmer Biomet Holdings Inc.、Terumo Corporation、Arteriocyte Medical Systems, Inc.、Exactech Inc.、Harvest Technologies Corp.、Nuo Therapeutics, Inc.、Haemonetics Corporation、Fresenius & SECo.K、MacSCo.K、St照
  • 本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球血小板浓缩系统市场报告涉及该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球血小板浓缩系统市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球血小板浓缩系统市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球血小板浓缩系统市场(依技术划分),2020 年至 2032 年

  • 血液分离技术
  • 单次旋转技术
  • 双旋技术

6. 全球血小板浓缩系统市场(依应用划分),2020 年至 2032 年

  • 整形外科
  • 整形外科和皮肤科
  • 神经病学
  • 心臟病学
  • 其他(眼科等)

7. 全球血小板浓缩系统市场(以最终用户划分),2020 年至 2032 年

  • 医院
  • 血库和输血中心
  • 门诊手术中心
  • 其他(研究设施、独立处理设施)

8. 2020 年至 2032 年全球血小板浓缩系统市场(按地区)

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第九章 竞争态势

  • Anthrax Inc.
  • Stryker Corporation
  • Johnson & Johnson's
  • Zimmer Biomet Holdings Inc.
  • Terumo Corporation
  • Arteriocyte Medical Systems, Inc.
  • Exactech Inc.
  • Harvest Technologies Corp.
  • Nuo Therapeutics, Inc.
  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Macopharma
  • BioIVT
  • Stago
  • Pall Corporation

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4324

Global Platelet Concentration Systems Market is estimated to be valued at USD 545.8 Mn in 2025 and is expected to reach USD 1,091.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 545.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.40% 2032 Value Projection: USD 1,091.1 Mn
Figure. Platelet Concentration Systems Market Share (%), By Region 2025
Platelet Concentration Systems Market - IMG1

Platelet concentration systems are pivotal medical devices that are used for concentrating platelets collected from donor's blood. The platelet-rich plasma or PRP derived from these systems contain a higher density of platelets than normal blood. PRP is defined as plasma with an elevated platelet concentration over that of normal plasma and can be created using centrifugation or gravity filtration of autologous blood. PRP is being extensively used in various regenerative medicine applications such as orthopedic surgeries for treating muscle, bone and joint injuries. The systems are equipped with advanced technologies that precisely separate platelets from other blood components through centrifugation followed by their careful compression into a concentrated formulation. They deliver safe and clinically effective volumes of autologous PRP which boost the body's natural healing abilities. With the aging global population and rise in sports injuries, the demand for less invasive platelet concentration techniques is augmenting.

Market Dynamics:

The global platelet concentration systems market is driven by the rising incidence of chronic diseases, sports injuries, and trauma cases that considerably benefit from PRP therapies. The growing adoption of tissue engineering approaches in reconstructive procedures and an increasing dependence on blood-derived products for wound care are fueling the market growth. However, high costs associated with these devices and lack of reimbursement policies for PRP-based treatments in some regions can impede widespread adoption. Moreover, each system requiring regulatory clearances poses challenges for market players. The untapped opportunities lie in developing economies with large geriatric populations and in utilizing platelet concentrate for new medical applications. Ongoing R&D for improving concentration accuracy, automating the process and expanding indications are expected to create lucrative prospects over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global platelet concentration systems market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2030), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global platelet concentration systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Anthrax Inc., Stryker Corporation, Johnson & Johnson's, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Macopharma, BioIVT, Stago, and Pall Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global platelet concentration systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet concentration systems market

Platelet Concentration Systems Market Detailed Segmentation:

  • By Technology
    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology
  • By Application
    • Orthopedics
    • Cosmetic Surgery and Dermatology
    • Neurology
    • Cardiology
    • Others (Ophthalmology and Others)
  • By End User
    • Hospital
    • Blood Banks and Transfusion Centers
    • Ambulatory Surgical Centers
    • Others (Research Laboratories, Stand-alone Processing Facilities)
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Anthrax Inc.
    • Stryker Corporation
    • Johnson & Johnson's
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Arteriocyte Medical Systems, Inc.
    • Exactech Inc.
    • Harvest Technologies Corp.
    • Nuo Therapeutics, Inc.
    • Haemonetics Corporation
    • Fresenius SE & Co. KGaA
    • Macopharma
    • BioIVT
    • Stago
    • Pall Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Platelet Concentration Systems Market, By Technology
    • Global Platelet Concentration Systems Market, By Application
    • Global Platelet Concentration Systems Market, By End User
    • Global Platelet Concentration Systems Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Platelet Concentration Systems Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Platelet Concentration Systems Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Apheresis Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Single Spin Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Double Spin Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Platelet Concentration Systems Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cosmetic Surgery and Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Ophthalmology and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Platelet Concentration Systems Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Blood Banks and Transfusion Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Research Laboratories, Stand-alone Processing Facilities)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Platelet Concentration Systems Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Anthrax Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson's
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Arteriocyte Medical Systems, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Exactech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Harvest Technologies Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nuo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Haemonetics Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fresenius SE & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Macopharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioIVT
  • Stago
  • Pall Corporation
  • Analyst Views

10. Section

  • Research Methodology
  • About us